REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 17th, 2023 • Financial Strategies Acquisition Corp. • Blank checks
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of February 13, 2023 by and among (i) Financial Strategies Acquisition Corp., a Delaware corporation (“Purchaser”), and (ii) the undersigned parties listed under Investor on the signature page hereto (each such party, together with any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, an “Investor” and collectively the “Investors”).
BUSINESS COMBINATION AGREEMENT by and among FINANCIAL STRATEGIES ACQUISITION CORP., as SPAC, FXCO MERGER SUB I, CORP. as Merger Sub, and AUSTIN BIOSCIENCES CORP., as the Company Dated as of February 13, 2023Business Combination Agreement • February 17th, 2023 • Financial Strategies Acquisition Corp. • Blank checks • Delaware
This Business Combination Agreement (this “Agreement”) is made and entered into as of February 13, 2023 by and among (i) Financial Strategies Acquisition Corp., a Delaware corporation (together with its successors, “SPAC”), (ii) FXCO Merger Sub I, Corp., a Delaware corporation and wholly owned subsidiary of the SPAC (“Merger Sub”), and (iii) Austin Biosciences Corp., a Delaware corporation (the “Company”). SPAC, Merger Sub and the Company are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”.
FORM OF LOCK-UP AGREEMENTLock-Up Agreement • February 17th, 2023 • Financial Strategies Acquisition Corp. • Blank checks
THIS LOCK-UP AGREEMENT (this “Agreement”) is dated as of February 13, 2023, by and between the undersigned: Celtic Asset & Equity Partners, Ltd., an Irish limited liability company, Austin Biosciences Sponsor I LLC, a Delaware limited liability company, James D. Story, Dr. Ramachandran Burgi-Krishnamurthy, and Raymond L. Brewer M.D., (collectively the “Holders”) and Financial Strategies Acquisition Corp., a Delaware corporation (“Purchaser”). Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Business Combination Agreement (the “BC Agreement”) entered into by and among (i) Purchaser, (ii) FXCO Merger Sub I Corp., a Delaware corporation and wholly owned subsidiary of Purchaser, and (iii) Austin Biosciences Corp., a Delaware corporation (the “Company”).
